SHISEIDO SYNCHRO SKIN LASTING FOUNDATION NEUTRAL 1- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION NEUTRAL 2- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION NEUTRAL 3- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION NEUTRAL 4- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION ROSE 2- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION ROSE 3- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION ROSE 4- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION GOLDEN 2- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION GOLDEN 3- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION GOLDEN 4- octinoxate and titanium dioxide liquid 
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION GOLDEN 5- octinoxate and titanium dioxide liquid 
SHISEIDO AMERICAS CORPORATION

----------

SHISEIDO SYNCHRO SKIN LASTING FOUNDATION

Drug Facts

Active ingredientsPurpose
OCTINOXATE 2.9%Sunscreen
TITANIUM DIOXIDE 2.4%Sunscreen

Uses

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

Inactive Ingredients

DIMETHICONE∙WATER∙TRIFLUOROPROPYLDIMETHYL/TRIMETHYLSILOXYSILICATE∙CAPRYLIC/CAPRIC TRIGLYCERIDE∙DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER∙PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE∙SD ALCOHOL 40-B∙MAGNESIUM MYRISTATE∙NYLON-12∙DIPHENYL DIMETHICONE/VINYL DIPHENYL DIMETHICONE/SILSESQUIOXANE CROSSPOLYMER∙DISTEARDIMONIUM HECTORITE∙POLYQUATERNIUM-51∙THYMUS SERPILLUM EXTRACT∙ALUMINUM HYDROXIDE∙ALUMINUM DISTEARATE∙POLYSILICONE-2∙GLYCERIN∙BHT∙ALCOHOL∙BUTYLENE GLYCOL∙TOCOPHEROL∙METHYL METHACRYLATE CROSSPOLYMER∙HYPERICUM ERECTUM FLOWER/LEAF/STEM EXTRACT∙TALC∙DIMETHICONE/PEG-10/15 CROSSPOLYMER∙SILICA∙ALUMINA∙POLYMETHYLSILSESQUIOXANE∙DIISOSTEARYL MALATE∙GLYCERYL DIISOSTEARATE∙DIPROPYLENE GLYCOL∙PHENOXYETHANOL∙FRAGRANCE∙TITANIUM DIOXIDE∙IRON OXIDES∙MICA∙RED 27∙

Other information

Questions or comments?

Call toll free 1-800-906-7503

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral 1

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral 1

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral 2

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral 2

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral 3

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral 3

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral 4

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Neutral 4

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Rose 2

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Rose 2

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Rose 3

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Rose 3

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Rose 4

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Rose 4

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden 2

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden 2

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden 3

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden 3

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden 4

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden 4

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden 5

SHISEIDO
GINZA TOKYO

SYNCHRO SKIN

Lasting
Liquid Foundation

Oil Free

BROAD SPECTRUM
SPF 20

Sunscreen

30mL 1 FL. OZ.

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton - Golden 5
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  NEUTRAL 1
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-261
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-261-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  NEUTRAL 2
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-262
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-262-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  NEUTRAL 3
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-263
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-263-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  NEUTRAL 4
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-264
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-264-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  ROSE 2
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-265
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-265-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  ROSE 3
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-266
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-266-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  ROSE 4
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-267
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-267-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  GOLDEN 2
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-268
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-268-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  GOLDEN 3
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-269
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-269-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  GOLDEN 4
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-270
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-270-101 in 1 CARTON02/01/2016
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/2016
SHISEIDO SYNCHRO SKIN LASTING FOUNDATION  GOLDEN 5
octinoxate and titanium dioxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-271
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE911 mg  in 30 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE754 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
MAGNESIUM MYRISTATE (UNII: Z1917F0578)  
NYLON-12 (UNII: 446U8J075B)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
THYMUS SERPYLLUM (UNII: 86H4S6K51N)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
HYPERICUM ERECTUM FLOWERING TOP (UNII: IT0296HQDC)  
TALC (UNII: 7SEV7J4R1U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) (UNII: 59Z907ZB69)  
DIISOSTEARYL MALATE (UNII: QBS8A3XZGQ)  
GLYCERYL DIISOSTEARATE (UNII: 68BAV42LRC)  
DIPROPYLENE GLYCOL (UNII: E107L85C40)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MICA (UNII: V8A1AW0880)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-271-101 in 1 CARTON02/01/201601/08/2021
130 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM02002/01/201601/08/2021
Labeler - SHISEIDO AMERICAS CORPORATION (193691821)
Establishment
NameAddressID/FEIBusiness Operations
SHISEIDO AMERICA INC.782677132manufacture(58411-261, 58411-262, 58411-263, 58411-264, 58411-265, 58411-266, 58411-267, 58411-268, 58411-269, 58411-270, 58411-271) , analysis(58411-261, 58411-262, 58411-263, 58411-264, 58411-265, 58411-266, 58411-267, 58411-268, 58411-269, 58411-270, 58411-271)

Revised: 10/2023
Document Id: 4f903124-5a35-4cde-8e01-13c87acdee3a
Set id: 3f1836e2-b6f5-4bc9-ba90-7f9b0aad2478
Version: 3
Effective Time: 20231023
 
SHISEIDO AMERICAS CORPORATION